These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17301931)

  • 1. [Cerebral imaging for Wilson disease].
    Andersen K; Südmeyer M; Saleh A
    Rofo; 2007 Mar; 179(3):225-33. PubMed ID: 17301931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does brain degeneration in Wilson disease involve not only copper but also iron accumulation?
    Skowrońska M; Litwin T; Dzieżyc K; Wierzchowska A; Członkowska A
    Neurol Neurochir Pol; 2013; 47(6):542-6. PubMed ID: 24374999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diffusion weighted MR: principles and clinical use in selected brain diseases].
    Nistri M; Mascalchi M; Moretti M; Tessa C; Politi LS; Orlandi I; Pellicanò G; Villari N
    Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wilson's disease. X-ray CT and MRI aspects of the brain in a case before treatment].
    Duchateau C; Laissy JP; Aubin ML; Mihout B; Thiebot J
    J Radiol; 1990 Mar; 71(3):229-31. PubMed ID: 2352215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
    Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI of the brain in Wilson disease: T2 signal loss under therapy.
    Engelbrecht V; Schlaug G; Hefter H; Kahn T; Mödder U
    J Comput Assist Tomogr; 1995; 19(4):635-8. PubMed ID: 7622700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation.
    Kim TJ; Kim IO; Kim WS; Cheon JE; Moon SG; Kwon JW; Seo JK; Yeon KM
    AJNR Am J Neuroradiol; 2006; 27(6):1373-8. PubMed ID: 16775300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal intensity loss on T2-weighted gradient-recalled echo magnetic resonance images in the basal ganglia in a patient with chronic hepatic encephalopathy.
    Dharmasaroja P
    Neurologist; 2010 Jul; 16(4):265-8. PubMed ID: 20592571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranial MR imaging in Wilson's disease.
    King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
    AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation.
    van Wassenaer-van Hall HN; van den Heuvel AG; Algra A; Hoogenraad TU; Mali WP
    Radiology; 1996 Feb; 198(2):531-6. PubMed ID: 8596862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroradiological studies of Wilson's disease by computed tomography and magnetic resonance imaging].
    Hori A; Hirose G; Kataoka S; Tsukada K; Kosoegawa H
    Rinsho Shinkeigaku; 1990 Jan; 30(1):7-16. PubMed ID: 2331824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
    Teraguchi M; Yamada H; Yoshida M; Nakayama Y; Kondo T; Ito H; Terada M; Kaneoke Y
    J Magn Reson Imaging; 2014 Nov; 40(5):1199-207. PubMed ID: 24395471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral magnetic resonance in Wilson's disease].
    Amato C; Bisceglie P; Moschini M
    Radiol Med; 1994 Dec; 88(6):752-7. PubMed ID: 7878232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
    Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
    Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts.
    van Wassenaer-van Hall HN; van den Heuvel AG; Jansen GH; Hoogenraad TU; Mali WP
    AJNR Am J Neuroradiol; 1995; 16(10):2021-7. PubMed ID: 8585490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early assessment of severe hypoxic-ischemic encephalopathy in neonates by diffusion-weighted magnetic resonance imaging techniques and its significance].
    Fu JH; Xue XD; Mao J; Chen LY; Wang XM
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):843-7. PubMed ID: 18282417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early white matter changes in Wilson disease.
    Verma A; Singh NN; Misra S
    J Assoc Physicians India; 2004 Jul; 52():578-9. PubMed ID: 15645987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in Wilson disease.
    van Wassenaer-van Hall HN
    Metab Brain Dis; 1997 Mar; 12(1):1-19. PubMed ID: 9101534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.